[artículo] 
inPsychiatric Clinics of North America > Año 2016 - Vol.39 - No.3 (Septiembre) . - pp. 477-486

Título :	Adverse effects of second-generation antipsychotics as adjuncts to antidepressants : are the risks worth the benefits?
Tipo de documento:	texto impreso
Autores:	Michael E. Thase, Autor
Fecha de publicación:	2020
Artículo en la página:	pp. 477-486
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Efectos adversos, Antipsicóticos de segunda generación, Terapia complementaria, Riesgos, Beneficios
Resumen:	Over the past decades, several adjunctive therapies have been introduced for treatment-resistant depression (TRD), and these strategies have ebbed and flowed in popularity. Currently, adjunctive therapy with the second-generation antipsychotics (SGAs) is most commonly used by psychiatrists.
Link:	./index.php?lvl=notice_display&id=24118

[artículo] Adverse effects of second-generation antipsychotics as adjuncts to antidepressants : are the risks worth the benefits? [texto impreso] / Michael E. Thase, Autor . - 2020 . - pp. 477-486.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2016 - Vol.39 - No.3 (Septiembre) . - pp. 477-486

Palabras clave:	Efectos adversos, Antipsicóticos de segunda generación, Terapia complementaria, Riesgos, Beneficios
Resumen:	Over the past decades, several adjunctive therapies have been introduced for treatment-resistant depression (TRD), and these strategies have ebbed and flowed in popularity. Currently, adjunctive therapy with the second-generation antipsychotics (SGAs) is most commonly used by psychiatrists.
Link:	./index.php?lvl=notice_display&id=24118